Mutations of p53 in thyroid carcinoma with an insular component

被引:45
|
作者
Takeuchi, Y [1 ]
Daa, T
Kashima, K
Yokoyama, S
Nakayama, I
Noguchi, S
机构
[1] Oita Med Univ, Dept Pathol, Hasama, Oita 8795593, Japan
[2] Noguchi Thyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
D O I
10.1089/thy.1999.9.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid carcinoma with an insular component (TCIC) is considered noteworthy in view of its peculiar histopathological features and clinicopathological behavior. The purpose of the present study was to clarify the rate of mutation in the p53 gene in TCIC as compared with rates in papillary and follicular carcinomas of the thyroid. Formalin-fixed and paraffin-embedded blocks of tissue from 46 cases of TCIC were analyzed. DNA was extracted from tissues and exons 5 through 8 of the p53 gene were amphfied by the polymerase chain reaction. Mutations were detected by analysis of single-strand conformation polymorphism. Of the 46 cases of TCIC, 6 had a mutation in exon 5, 2 in exon 7, and 5 in exon 8, while 1 case had mutations in all exons examined. The mutation rate of the p53 gene in TCIC was 38%. Immunostaining revealed overexpression of p53 in nuclei that were mainly in areas of the insular component rather than in surrounding areas of well-differentiated carcinoma. The frequency of positive immunostaining in TCIC was 53%. Considering that TCIC is intermediate between papillary plus follicular carcinoma and anaplastic carcinoma in terms of survival and the rate of mutation of the p53 gene, we can speculate that mutation in the p53 gene might be associated with the insular component and might play an important role in the clinicopathological behavior of thyroid carcinoma.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [21] p53 mutations and expression in breast carcinoma in situ
    Lukas, J
    Niu, N
    Press, MF
    MODERN PATHOLOGY, 1998, 11 (01) : 164A - 164A
  • [22] The expression and significance of hTERT and P53 in thyroid carcinoma
    Xiong-Wei Huo
    Journal of Pharmaceutical Analysis, 2010, 22 (02) : 127 - 130
  • [23] RAS AND p53 EXPRESSION IN HUMAN THYROID CARCINOMA
    李晓曦
    吴惠茜
    赵国华
    王深明
    陈国锐
    Chinese Journal of Cancer Research, 2000, (04) : 296 - 299
  • [24] The expression and significance of hTERT and P53 in thyroid carcinoma
    XiongWei HuoYanFeng GaoQingYong MaXueJun SunDepartment of General Surgerythe First Affiliated HospitalMedical School of Xian Jiaotong UniversityXian China
    Academic Journal of Xi'an Jiaotong University, 2010, 22 (02) : 127 - 130
  • [25] Insular component as a risk factor of thyroid carcinoma
    Sasaki, A
    Daa, T
    Kashima, K
    Yokoyama, S
    Nakayama, I
    Noguchi, S
    PATHOLOGY INTERNATIONAL, 1996, 46 (12) : 939 - 946
  • [26] High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma
    Anzola, M
    Saiz, A
    Cuevas, N
    Lopez-Martinez, M
    Martinez de Pancorbo, MA
    Burgos, JJ
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (06) : 502 - 510
  • [27] Bcl-2 and p53 expression in insular and in well-differentiated thyroid carcinomas with an insular pattern
    Pestereli, HE
    Ögüs, M
    Ören, N
    Karpuzoglu, G
    Karpuzoglu, T
    ENDOCRINE PATHOLOGY, 2001, 12 (03) : 301 - 305
  • [28] Bcl-2 and p53 expression in insular and in well-differentiated thyroid carcinomas with an insular pattern
    Hadice Elif Peştereli
    Mehmet Öğüş
    Nural Ören
    Gülten Karpuzoğlu
    Tuncer Karpuzoğlu
    Endocrine Pathology, 2001, 12 : 301 - 305
  • [29] THE ROLE OF P53 MUTATIONS IN BILATERAL BREAST-CARCINOMA
    ACKERMAN, J
    BAUNOCH, DA
    GIMOTTY, P
    GEORGE, J
    LANE, MA
    DAWSON, PJ
    MODERN PATHOLOGY, 1995, 8 (03) : 244 - 248
  • [30] Multiple mutations of the p53 gene in human mammary carcinoma
    Meng, L
    Lin, L
    Zhang, H
    Nassiri, M
    Morales, AR
    Nadji, M
    MUTATION RESEARCH-DNA REPAIR, 1999, 435 (03): : 263 - 269